On April 23, 2019, Prof.Piyamitr Sritara, Dean, along with Prof.Sirintara Singhara Na Ayudhaya, Deputy Dean for International Relations; Prof.Boonsong Ongphiphadhanakul, Deputy Dean for Research; Assoc.Prof.Renu Pookboonmee, Director of Ramathibodi School of Nursing and Asst.Prof.Suchin Worawichawong, Assistant Dean for International Relations, provided a warm welcome to the group of 14 delegates from Peking University Health Science Center, China. The purpose to visit is to exchange the views on nursing of patients with the chronic diseases as well as explore our collaborative activities in the fields of student exchange, joint research and more.
The NUS Enterprise Summer Programme on Entrepreneurship is targeted at undergraduate students* currently enrolled in university, majoring in any discipline.
The 2019 NUS Enterprise Summer Programme on Entrepreneurship will be held from 14 - 27 July 2019.
Applications are now open from 5 March to 26 April 2019! Please click https://enterprise.nus.edu.sg/educate/summer-programme for more information and do not forget to contact your IR in order to send your name to MUIR for the next step!
Mahidol and Macquarie University Centre for International Education (MCIE): ‘Alone we can do so little, Together we can do so much’
The signing ceremony was attended by H.E. Allan McKinnon, Australian Ambassador to Thailand, Prof. Bruce Dowton, VC and President of Macquarie University and Prof. Banchong Mahaisavariya, Acting President of Mahidol University, along with all deans and executives. All credits go to all MQ colleagues, MU Deans and Directors who have walked the talk together since September last year. We are indebted to H.E.Prof. Udom Kachintorn, Deputy Minister for Education and Ajahn Preecha Soontranan for heading the delegation to explore the possibility, VP Chuthamanee Suthisisang and VP Suwat Benjaponpitak for showing to our partner from the very beginning that Mahidol University is a trusted brand and we are ready to deliver. We are also grateful for the kind hospitality of Assoc. Prof. Chulathida Chomchai, M.D., Dean, MU International College, for allocating a co-shared space for MCIE. Also, more credits go to Watinee Kharnwong and Busarin Sinthunavarat from the Australian Embassy for their continuous support on this initiative as well as all MUIR team.
DUBLIN and BANGKOK – March 22, 2019 – Medtronic plc (NYSE:MDT), a global leader in medical technology, services and solutions, today signed a Memorandum of Understanding (MOU) and the Value-Based Healthcare (VBHC) Cardiac Implantable Electronic Devices (CIEDs) Infection Reduction Outcomes Protection Program with Faculty of Medicine Ramathibodi Hospital, Mahidol University-one of Thailand’s leading university hospitals- delivering super tertiary care. CIEDs include devices such as pacemakers, implantable cardioverter defibrillators, and cardiac resynchronization devices.
The MOU aims to develop a strategic partnership that includes setting up a joint Incubator and Innovation Platform to drive innovation, research, and VBHC in Thailand. The strategic partnership will focus on promoting innovation and research for new technologies, enhancing patient and staff experience, advancing clinical performance and education, and establishing a foundation for the delivery of VBHC. Medtronic will support Faculty of Medicine Ramathibodi Hospital, Mahidol University, in achieving a higher quality of care, greater clinical efficiency, improved patient outcomes, and broader access to therapies.
A key feature of the partnership will be a collaboration with the Medical Innovations Development Center (MIND) at Faculty of Medicine Ramathibodi Hospital, Mahidol University, to accelerate breakthrough innovations and inventions in medical technology with the goal of improving the lives of patients in Thailand. Potential areas of exploration include technology development, clinical research, data science, real world data and evidence, and training and education.
In addition, the VBHC CIED Infection Reduction Outcomes Protection Program demonstrates the commitment to improving outcomes for patients with CIEDs between Medtronic and Faculty of Medicine Ramathibodi Hospital, Mahidol University. Recent results from the landmark Worldwide Randomized Antibiotic Envelope Infection Prevention Trial (WRAP-IT), published in The New England Journal of Medicine1, demonstrated that the use of an Absorbable Antibacterial Envelope reduced the risk of major infection by 40 percent, and pocket infection by 61 percent, in patients with CIEDs, compared to standard-of-care pre-operative antibiotics. Under the program, any patient implanted with a Medtronic CIED and Absorbable Antibacterial Envelope who develops a device infection within 12 months of the date of implant will be provided with an equivalent replacement device, related leads and accessories, and an antibacterial envelope.
Healthcare is facing immense challenges. From shifting payment models to problems of access, providers and payers are struggling to improve patient outcomes and lower overall costs. In Thailand, some of the biggest challenges for healthcare service providers like public hospitals are the high demand on services, budgetary limitations, inefficient processes, and long waiting time for patients. Leveraging their mutual expertise and resources, Medtronic and Faculty of Medicine Ramathibodi Hospital, Mahidol University, are partnering to improve care at the same or reduced cost, while increasing access for more patients.
“Our faculty is focused on driving innovation and service models to deliver economic and social value to our patients. This partnership will add strongly to the specialized work we are doing at the MIND Center. The joint Incubator and Innovation Platform with Medtronic will allow both parties to bring our strengths and capabilities to the table – working together to inspire and stimulate innovation in Thailand. In the long run, we will strive to provide our patients with high quality, high value care,” said Professor Piyamitr Sritara, dean of the Faculty of Medicine Ramathibodi Hospital, Mahidol University.
“This partnership is exciting not only for Medtronic and Faculty of Medicine Ramathibodi Hospital, Mahidol University, but also for the broader healthcare community. Thailand has been very progressive in its desire to move toward a value-based healthcare model. Our alliance will contribute to this journey by continuing to focus on improving outcomes that are meaningful for patients at the lowest possible costs. This will set new standards for providing quality healthcare in a sustainable way. We look forward to the new possibilities that this partnership will bring,” said Omar Ishrak, chairman and CEO of Medtronic.
Medtronic plc (www.medtronic.com), headquartered in Dublin, Ireland, is among the world’s largest medical technology, services and solutions companies – alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 86,000 people worldwide, serving physicians, hospitals and patients in more than 150 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.
Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.
March 24, 2019 at Ariyana Convention Centre, Danang City, Vietnam
Prof. Wg. Cdr. Sirintara Singhara na Ayudhaya, MD, Deputy Dean for International Relations, the Faculty of Medicine Ramathibodi Hospital, precisely attended and gave welcome and introduction at PLANET Course 2019 - Pierre Lasjaunias Neurovascular Education Team Conference; session 1.
The program has continued to run successfully every year in various countries around the world and is recognized as the premier education program of teaching fundamentals of Interventional Neuroradiology worldwide.
Session I covered vascular anatomy of the maxillo-facial, skull base and central nervous system vasculature. Other topics includes skull base tumors, dural arteriovenous malformations and traumatic lesions of the head and neck vasculature. Further topics were spinal cord vascular anatomy, vascular tumors and malformations as well as vascular malformations of the head and neck region.
Looking for a chance for short training in Japan? It's your time!
Tohoku University Graduate School of Medicine has opened one-week training in November 2019 called Japan-Asia Youth Exchange Program in Science: "Sakura Science Program"
Purpose is to accept the Asian students who are interested in enrolling for Master's course or Ph.D. course to Tohoku University Graduate School of Medicine in the future for one week (Nov 25-29) to expose the actual laboratory.
The conditions are
(1) under 40 years old
(2) non PhD
(3) no experience traveling Japan after the college (except for ordinary sightseeing and attending meeting).
The expenses including accommodation and travel expenses and daily allowance will be support by the host!
*The Departement available are as follows:
- Otolaryngology-Head and Neck Surgery
- Breast and Endocrine Surgery
- International Cooperation for Disaster Medicine
For more information, please follow the link as attached. Exclusive for Ramathibodi's medical students, please contact to the IR office (Zai) at 02-201-2763.
Prof.Piyamitr Sritara, M.D., Dean, Faculty of Medicine Ramathibodi Hospital; along with Prof. Alisa Limsuwan, M.D., Deputy Dean for Ramathibodi School of Hospital Management provided a warm welcome to Prof. Bryan McNally, MD, MPH, Professor of Emergency Medicine, Executive Director CARES, Emory University School of Medicine, on occasion of paying courtesy visit and calling upon Ramathibodi’s Department of Emergency Medicine.
March 21, 2019, The group 5 of student member from Tropical Medicine Association, Juntendo University, Japan; led by Prof. Kazuhisa Takahashi, M.D., Head of Division of Respiratory Medicine, visited the Faculty of Medicine Ramathibodi Hospital. The purpose of visiting are to listen for Ramathibodi's national strategic plan toward Tuberculosis; kindly lectured by Assoc Prof Prapaporn Pisitkun, MD, Dip.
March 20, 2019, Assistant Professor Mariko Saito-Obata, as representative from International Exchange Office, Tohoku University Graduate School of Medicine, Japan kindly visited Faculty of Medicine Ramathibodi Hospital. The main purpose of her visit are to call upon Ramathibodi’s facilities provided for exchange students as well as update about the 1 week exchange programs opening soon in Tohoku University Graduate School of Medicine. In this occasion Ms.Katesarin Suwanwiriya, Head of International Relation Section, precisely provide a warm welcom.
March 6, 2019 at Room no.714, Medical Learning Resource Center and Ramathibodi School of Nursing Building; Prof.Sirintara Singhara na Ayudhaya, M.D., Deputy Dean for International Relations provided welcome for Mr.Ryoji Noritake, CEO of Health and Global Policy Institute (HGPI) and dementia care experts from Japan including Ministry of Health, Labour and Welfare, Dementia Friendship Club, National Center for Geriatrics and Gerontology; attending THAILAND – JAPAN DEMENTIA CONFERENCE - Redesigning Dementia for People with Dementia. On this occasion Deputy Dean for International Relations of Ramathibodi kindly gave the welcome speech and participated the conference.
วันที่ 6 มีนาคม 2562 ณ ห้องประชุม 714 อาคารเรียนและปฏิบัติการรวม ด้านการแพทย์และโรงเรียนพยาบาลรามาธิบดี ศาสตราจารย์แพทย์หญิงศิรินธรา สิงหรา ณ อยุธยา รองคณบดีฝ่ายวิเทศสัมพันธ์ ให้โดยการนี้ให้การต้อนรับ Mr.Ryoji Noritake CEO ของ Health and Global Policy Institute (HGPI) และคณะผู้เชี่ยวชาญด้านโรคสมองเสื่อมจากประเทศญี่ปุ่นจากหลากหลายองค์กร อาทิ Ministry of Health, Labour and Welfare, Dementia Friendship Club, National Center for Geriatrics and Gerontology ในโอกาสเดินทางมาบรรยาย งานประชุมวิชาการ THAILAND – JAPAN DEMENTIA CONFERENCE ภายใต้หัวข้อหลัก Redesigning Dementia for People with Dementia ในโอกาสนี้ศาสตราจารย์แพทย์หญิงศิรินธรา สิงหรา ณ อยุธยา กล่าวเปิดงาน และร่วมฟังบรรยาย
โดยการประชุมดังกล่าวเป็นความร่วมมือระหว่างคณะแพทยศาสตร์โรงพยาบาลรามาธิบดี มหาวิทยาลัยมหิดล และ HGPI ประเทศญี่ปุ่น มีวัตถุประสงค์เพื่อเป็นเวทีในการแลกเปลี่ยนความรู้ ประสบการณ์การทำงาน รวมทั้งสร้างเครือข่ายผู้เชี่ยวชาญด้านโรคสมองเสื่อม ทั้งในประเทศไทยและประเทศญี่ปุ่น
On March 5, 2019 at Department of Communication Sciences and Disorder; Prof.Sirintara Singhara na Ayudhaya, M.D., Deputy Dean for International Relations, along with Asst.Prof. Suchin Worawichawong, M.D., Assistant Dean for International RelationsAssoc. Prof. Krisna Lertsukprasert, Head of Department of Communication Sciences and Disorders and her team provided warm welcome to the group of executives from Macquarie University including Prof. David Wilkinson, Deputy Vice-Chancellor (Engagement); Ms. Nicole Brigg, Pro Vice-Chancellor (International) and Mr. Matthew Monkhouse, Director, Southeast Asia and Eurasia. The main purpose of this visit was to have collaborative discussion towards working on accelerate the project of establishing the ASEAN Hearing Hub and Communication Sciences Center within Ramathibodi.
You are invited!
THAILAND – JAPAN DEMENTIA CONFERENCE
-- Redesigning Dementia for People with Dementia –
Date: March 6, 2019 (13:00-16:00)
Venue: Meeting room no.714, Medical Learning Resource Center and Ramathibodi School of Nursing Building, Faculty of Medicine Ramathibodi Hospital, Mahidol University
Online registration is ready at